Rodić Predrag, Lakočević Milan, Pavlović Sonja, Đurašević Teodora Karan, Kostić Tatjana, Vuković Nada Suvajdžić, Šumarac Zorica, Petakov Milan, Janić Dragana
School of Medicine, University of Belgrade, Belgrade, Serbia.
Department of Hematology and Oncology, University Children's Hospital, Belgrade, Serbia.
J Med Biochem. 2018 Jul 1;37(3):307-312. doi: 10.1515/jomb-2017-0061. eCollection 2018 Jul.
Several studies support the evidence of increased incidence of hematological complications in Gaucher disease including monoclonal and polyclonal gammopathies and blood malignancies, especially multiple myeloma.
Serum concentrations of immunoglobulins and PCR analysis of the IGH gene rearrangements were performed. The clonal PCR products were directly sequenced and analyzed with the appropriate database and tools. Serum monoclonal proteins were detected and identified by electrophoresis.
Among 27 Gaucher patients, clonal IGH rearrangement was discovered in eight, with 5/8 having also serum monoclonal protein. Elevated immunoglobulins were detected in 9/27 patients. Follow-up data for 17 patients showed that the clonal rearrangement remained the same in four of them, however, in one patient it disappeared after the follow-up period. The remaining 12/17 patients were without previous IGH clonal rearrangement and remained so after the follow-up.
Although clonal expansion may occur relatively early in the disease course, at least judging by the IGH gene rearrangements in Gaucher patients, the detected clones may be transient. A careful clinical follow-up in these patients is mandatory, including monitoring for lymphoid neoplasms, especially multiple myeloma.
多项研究支持高雪氏病血液学并发症发病率增加的证据,包括单克隆和多克隆丙种球蛋白病以及血液系统恶性肿瘤,尤其是多发性骨髓瘤。
检测血清免疫球蛋白浓度并进行IGH基因重排的PCR分析。对克隆性PCR产物进行直接测序,并使用适当的数据库和工具进行分析。通过电泳检测和鉴定血清单克隆蛋白。
在27例高雪氏病患者中,8例发现克隆性IGH重排,其中5/8同时伴有血清单克隆蛋白。9/27的患者检测到免疫球蛋白升高。17例患者的随访数据显示,其中4例克隆性重排保持不变,然而,1例患者在随访期后克隆性重排消失。其余12/17例患者之前无IGH克隆性重排,随访后仍未出现。
尽管克隆性扩增可能在疾病进程中相对较早发生,至少从高雪氏病患者的IGH基因重排来看是这样,但检测到的克隆可能是短暂的。对这些患者进行仔细的临床随访是必要的,包括监测淋巴系统肿瘤,尤其是多发性骨髓瘤。